Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecNCT07332000CADLPhase 2Recruiting2027-02Estimated
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASHNCT07335601MDGLPhase 2Recruiting2028-08Estimated
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)NCT07355075Turn TherapeuticsPhase 2, Phase 3Recruiting2027-01-20Estimated
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)NCT07359846Generate BiomedicinesPhase 3Recruiting2029-01Estimated
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque PsoriasisNCT07362017Vanda PharmaceuticalsPhase 3Recruiting2028-08Estimated
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute SchizophreniaNCT07363577LBRXPhase 3Recruiting2027-06Estimated
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.NCT07365319Eikon TherapeuticsPhase 2, Phase 3Recruiting2035-12-31Estimated
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)NCT07365332Inhibikase TherapeuticsPhase 3Recruiting2029-06Estimated
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of AgeNCT07365826PCVXPhase 3Active not recruiting2027-03Estimated
Study of DISC-0974-201 in Participants With IBD and AnemiaNCT07368972IRONPhase 2Recruiting2026-10Estimated
52-week Open Label Safety-Tolerability StudyNCT07369154LBRXPhase 3Recruiting2028-12Estimated
This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate InfluenzaNCT07371650TRAWPhase 2Active not recruiting2026-12Estimated
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in AdultsNCT07382167ArdelyxPhase 3Recruiting2027-02-26Estimated
Descartes-08 in Autoantibody MyositisNCT07391605Cartesian TherapeuticsPhase 2Recruiting2027-11Estimated
Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E CigarettesNCT07392125Achieve Life SciencesPhase 3Not yet recruiting2026-11-15Estimated
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research DesignNCT07398417AXSMPhase 3Recruiting2028-03Estimated
Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With KeratoconusNCT07400952Glaukos CorporationPhase 2Recruiting2027-04Estimated
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex BlepharitisNCT07400965Glaukos CorporationPhase 2Recruiting2026-09Estimated
Open-Label Extension Study to Pioneer Study 6058-SCD-101NCT07401823Fulcrum TherapeuticsPhase 2Enrolling by invitation2030-02-04Estimated
A Clinical Trial Evaluating Patients With Primary Vitreoretinal LymphomaNCT07402876ALDXPhase 3Recruiting2026-12Estimated
Phase 3 Study of Telitacicept in Active Primary Sjögren's DiseaseNCT07404865Vor BiopharmaPhase 3Recruiting2028-12Estimated
An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe SyndromeNCT07410455Can-Fite BioPharmaPhase 2Not yet recruiting2027-08-31Estimated
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal VaccinationNCT07425392PCVXPhase 3Active not recruiting2027-03Estimated
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)NCT07428499ADARx Pharmaceuticals, Inc.Phase 3Recruiting2030-06-30Estimated
A Study of Zanzalintinib in Participants With Recurrent or Progressive MeningiomaNCT07428616ExelixisPhase 2Recruiting2028-02-29Estimated
Phase 2 Study Evaluating Apitegromab for the Treatment of FSHDNCT07435129Scholar Rock, Inc.Phase 2Recruiting2028-06Estimated
Long-Term Open-Label Extension Study of Oral LevosimendanNCT07436689TENXPhase 3Enrolling by invitation2029-03Estimated
Study to Evaluate Soquelitinib in Participants With Moderate to Severe ADNCT07441395CRVSPhase 2Recruiting2027-06Estimated
Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)NCT07443202TARSPhase 2Enrolling by invitation2026-12-31Estimated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal CancerNCT07446322Oncolytics BiotechPhase 2Recruiting2027-08-30Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.